FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN OR ANIMAL USE

CAGRILINTIDE 5MG

(1 customer review)

$45.00

This product is supplied for laboratory research use only (RUO) and is intended solely for qualified professionals in a controlled research setting. It is not a drug, food, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use or for any diagnostic, therapeutic, or clinical application. It is not for household use.

No statement on this page has been evaluated by the U.S. Food and Drug Administration. Nothing herein is intended to diagnose, treat, cure, or prevent any disease, nor to suggest any dosage, route, or method of administration. ARC Compounds LLC makes no representation or warranty, express or implied, regarding fitness for any purpose other than research and provides no medical or professional advice. The purchaser and end user assume full responsibility for safe handling, storage, and use in accordance with all applicable laws, regulations, and institutional safety protocols, and accept all associated risk and liability.

6 in stock

Pay with:VISAMastercardAMEXKlarnaAfterpay
Research-use limitation: This item is offered solely for legitimate laboratory research. It is not intended for human or animal use and is not represented as a medicine, supplement, cosmetic, or food product.
Category:

Description

Cagrilintide is a research-use-only, long-acting amylin analogue evaluated in bioenergetic pathway studies. Investigations probe metabolic signaling, satiety-linked energy balance, and mitochondrial efficiency under stress. Not intended for diagnostic or therapeutic use.

  • Bioenergetic signaling and energy regulation models
  • Metabolic pathway and redox balance exploration
  • Mitochondrial efficiency under energetic stress

1 review for CAGRILINTIDE 5MG

  1. Paula fig (verified owner)

    Living this and the overall experience with the seller was great. 10/10 recommend getting all ur items from him.

Add a review

Your email address will not be published. Required fields are marked *